These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 33203690)
1. Proteomic and Systematic Functional Profiling Unveils Citral Targeting Antibiotic Resistance, Antioxidant Defense, and Biofilm-Associated Two-Component Systems of Acinetobacter baumannii To Encumber Biofilm and Virulence Traits. Selvaraj A; Valliammai A; Muthuramalingam P; Sethupathy S; Subramenium GA; Ramesh M; Pandian SK mSystems; 2020 Nov; 5(6):. PubMed ID: 33203690 [No Abstract] [Full Text] [Related]
2. Proteomic profiling unveils citral modulating expression of IsaA, CodY and SaeS to inhibit biofilm and virulence in methicillin-resistant Staphylococcus aureus. Valliammai A; Sethupathy S; Ananthi S; Priya A; Selvaraj A; Nivetha V; Aravindraja C; Mahalingam S; Pandian SK Int J Biol Macromol; 2020 Apr; ():. PubMed ID: 32360467 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of Acinetobacter baumannii in biofilm and planktonic growth mode. Shin JH; Lee HW; Kim SM; Kim J J Microbiol; 2009 Dec; 47(6):728-35. PubMed ID: 20127467 [TBL] [Abstract][Full Text] [Related]
4. Antibiofilm and Antivirulence Efficacies of Flavonoids and Curcumin Against Raorane CJ; Lee JH; Kim YG; Rajasekharan SK; García-Contreras R; Lee J Front Microbiol; 2019; 10():990. PubMed ID: 31134028 [No Abstract] [Full Text] [Related]
5. Proteomic and functional analyses reveal a unique lifestyle for Acinetobacter baumannii biofilms and a key role for histidine metabolism. Cabral MP; Soares NC; Aranda J; Parreira JR; Rumbo C; Poza M; Valle J; Calamia V; Lasa I; Bou G J Proteome Res; 2011 Aug; 10(8):3399-417. PubMed ID: 21612302 [TBL] [Abstract][Full Text] [Related]
6. Antibiofilm and antivirulence efficacy of myrtenol enhances the antibiotic susceptibility of Acinetobacter baumannii. Selvaraj A; Valliammai A; Sivasankar C; Suba M; Sakthivel G; Pandian SK Sci Rep; 2020 Dec; 10(1):21975. PubMed ID: 33319862 [TBL] [Abstract][Full Text] [Related]
8. Variable spontaneous mutation rate in clinical strains of multidrug-resistant Acinetobacter baumannii and differentially expressed proteins in a hypermutator strain. Karami-Zarandi M; Douraghi M; Vaziri B; Adibhesami H; Rahbar M; Yaseri M Mutat Res; 2017 Aug; 800-802():37-45. PubMed ID: 28646746 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients. Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602 [TBL] [Abstract][Full Text] [Related]
10. Identification of immunogenic proteins of the bacterium Acinetobacter baumannii using a proteomic approach. Fajardo Bonin R; Chapeaurouge A; Perales J; da Silva JG; do Nascimento HJ; D'Alincourt Carvalho Assef AP; Moreno Senna JP Proteomics Clin Appl; 2014 Dec; 8(11-12):916-23. PubMed ID: 24899143 [TBL] [Abstract][Full Text] [Related]
11. Virulence characteristics of multidrug resistant biofilm forming Acinetobacter baumannii isolated from intensive care unit patients. Zeighami H; Valadkhani F; Shapouri R; Samadi E; Haghi F BMC Infect Dis; 2019 Jul; 19(1):629. PubMed ID: 31315572 [TBL] [Abstract][Full Text] [Related]
12. Clinical isolates of Acinetobacter baumannii from a Portuguese hospital: PFGE characterization, antibiotic susceptibility and biofilm-forming ability. Duarte A; Ferreira S; Almeida S; Domingues FC Comp Immunol Microbiol Infect Dis; 2016 Apr; 45():29-33. PubMed ID: 27012918 [TBL] [Abstract][Full Text] [Related]
13. Biofilm inhibitory efficiency of phytol in combination with cefotaxime against nosocomial pathogen Acinetobacter baumannii. Ramanathan S; Arunachalam K; Chandran S; Selvaraj R; Shunmugiah KP; Arumugam VR J Appl Microbiol; 2018 Jul; 125(1):56-71. PubMed ID: 29473983 [TBL] [Abstract][Full Text] [Related]
14. Convergence of Biofilm Formation and Antibiotic Resistance in Roy S; Chowdhury G; Mukhopadhyay AK; Dutta S; Basu S Front Med (Lausanne); 2022; 9():793615. PubMed ID: 35402433 [No Abstract] [Full Text] [Related]
15. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates]. Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717 [TBL] [Abstract][Full Text] [Related]
16. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Thummeepak R; Kongthai P; Leungtongkam U; Sitthisak S Int Microbiol; 2016 Jun; 19(2):121-129. PubMed ID: 27845499 [TBL] [Abstract][Full Text] [Related]
17. Gene expressing analysis indicates the role of Pyrogallol as a novel antibiofilm and antivirulence agent against Acinetobacter baumannii. Abirami G; Durgadevi R; Velmurugan P; Ravi AV Arch Microbiol; 2021 Jan; 203(1):251-260. PubMed ID: 32918098 [TBL] [Abstract][Full Text] [Related]
18. Extracellular proteome of a highly invasive multidrug-resistant clinical strain of Acinetobacter baumannii. Mendez JA; Soares NC; Mateos J; Gayoso C; Rumbo C; Aranda J; Tomas M; Bou G J Proteome Res; 2012 Dec; 11(12):5678-94. PubMed ID: 22966805 [TBL] [Abstract][Full Text] [Related]
19. Study of genetic diversity, biofilm formation, and detection of Carbapenemase, MBL, ESBL, and tetracycline resistance genes in multidrug-resistant Ranjbar R; Farahani A Antimicrob Resist Infect Control; 2019; 8():172. PubMed ID: 31719975 [TBL] [Abstract][Full Text] [Related]
20. Iron limitation enhances acyl homoserine lactone (AHL) production and biofilm formation in clinical isolates of Acinetobacter baumannii. Modarresi F; Azizi O; Shakibaie MR; Motamedifar M; Mosadegh E; Mansouri S Virulence; 2015; 6(2):152-61. PubMed ID: 25622119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]